The growing awareness about the importance of child healthcare and well-being is driving the market for pediatric vaccines globally. Pediatric vaccine continues to be one of the booming segment for the pharmaceutical companies. Pediatric vaccines are used in the prevention of numerous diseases, such as Hepatitis- A and -B. Measles, Influenza, Polio, Tetanus, and Diphtheria. Increasing government and non-government funding for development of vaccine is the major driver for the pediatric vaccine market. The rising incidence of diseases such as influenza, hepatitis and HPV has also fueled the demand for the global pediatric vaccines market. The vaccines industry also faces hindrances such as vaccine safety, shortages and delays, vaccine development time line as well as entry barriers for new manufacturers.
Pediatric Vaccines Market - Disease Wise Analysis
The pneumococcal vaccines accounts for maximum share of the pediatric vaccines market. The DTaP vaccines were the second most popular segment in the year 2015. It is competing closely with MMRV vaccines which controlled XX% share of the pediatric vaccines market in 2015. The rotavirus and influenza vaccines stands at fourth and fifth spots respectively in 2015. While vaccines for Polio, meningococcal and HPV are also gaining ground in pediatric vaccines market landscape.
Pediatric Vaccines Market - Company Analysis
Pfizer is the leading player in the pediatric vaccines market being followed by GSK at the second spot. Merck grabbed the third spot in the Global pediatric vaccines landscape as it provides a wide array of vaccines for various diseases. Sanofi Pasteur and Medimmune stands at the fourth and fifth position respectively in the pediatric vaccines market, while, bioCSl captures least share of the global pediatric vaccines market.
Pediatric Vaccines Market - Disease Wise Company Sales Analysis
GSK and Sanofi Pasteur generates maximum pediatric vaccines revenue from DTaP vaccines. The MMRV vaccines accounts for maximum share of the total Merck pediatric vaccines sales, while, Pfizer’s main source of pediatric vaccines sales revenue is the pneumococcal vaccines.
Sanofi Pasteur is the dominant player in the DTaP, influenza and meningococcal pediatric vaccines landscape, while in the hepatitis vaccines market, GSK is at the forefront and is expected to maintain its dominancy over a longer period of time. Pfizer is the clear leader in pneumococcal vaccines market. Merck is the leading player in the MMRV and rotavirus vaccines market.
Pediatric Vaccines Market - Regional Distribution
On a regional basis the United States comprises the single largest market for pediatric vaccines being closely followed by Europe. Japan’s pediatric vaccines market share is expected to remain flat during the forecasting period. China accounts for XX% share of the global pediatric vaccines market in 2015. South America and India are competing closely with each other to grab maximum share of the pediatric vaccines market pie.
iGATE RESEARCH report entitled “Pediatric Vaccines Market, Company Sales and Forecast - Global Analysis” provides a comprehensive analysis of the fast-evolving high growth vaccines market. This 205 Page report with 116 Figures and 6 Tables has been analyzed from 7 viewpoints:
1. Global Pediatric Vaccines Market - Disease Wise Analysis to 2021 2. Global Pediatric Vaccines Market - Company Sales Analysis and Strategic Alliances 3. Global Pediatric Vaccines - Disease Wise Company Sales and Forecast to 2021 4. Pediatric Vaccines Disease Wise Market - Company Share and Forecast 5. Global Pediatric Vaccines Market - Regional Distribution to 2021 6. Major Vaccines Related Acquisitions (2005-2015) 7. Pediatric Vaccines Market - Driving Factors and Challenges
Global Pediatric Vaccines Market - Disease Wise Analysis to 2021 (10 Disease Analysed)
Global Pediatric Vaccines Market - Geographical Distribution to 2021 (8 Region Analysed)
1. United States 2. North America/Caribbean 3. South America 4. Europe 5. Japan 6. India 7. China 8. Rest of the World
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
Our reports have been used by over 10K customers, including:
Rabies Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Rabies Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Rabies Clinical trials scenario.This report provides top line data relating to the clinical trials on Rabies. Report includes...
Influenzavirus B Infections Global Clinical Trials Review, H2, 2020 Summary Clinical trial report, “Influenzavirus B Infections Global Clinical Trials Review, H2, 2020" provides an overview of Influenzavirus B Infections Clinical trials scenario.This report provides top line data relating to the...
Mumps - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Mumps - Pipeline Review, H2 2020, provides an overview of the Mumps (Infectious Disease) pipeline landscape. Mumps is a contagious disease that leads to painful swelling of the salivary...
Influenzavirus A Infections - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Influenzavirus A Infections Global Clinical Trials Review, H2, 2020" provides an overview of Influenzavirus A Infections Clinical trials scenario.This report provides top line data relating to the...